C. K. Cooper & Company, an independent, full-service investment bank, headquartered in Irvine, Calif., announced today that Suraj Kalia has joined the firm as a Managing Director in the Healthcare Research Department.
Over the past 9 years, Mr. Kalia has focused primarily on Medical Device issuers having developed a reputation as a thought leader in the identification of emerging technologies. Previously at Rodman and Renshaw, Mr. Kalia covered 22 issuers ranging in market capitalizations from $20 million to $10 billion. Prior to joining Rodman and Renshaw in 2007, Mr, Kalia provided research at Sanders Morris Harris, Piper Jaffray & Co. and Northland Securities.
Commenting on the addition to the Healthcare Team at C. K. Cooper & Company, Bilal Basrai Director in the Corporate Finance Group – Healthcare commented, “Suraj’s broad range of experience and prior coverage of healthcare names fits well with our core investment thesis. We expect him to bring immediate value to our clients through his insightful research. We are pleased and excited to have Suraj as part of the team.”
Mr. Kalia added, “I look forward to being part of the team tasked with building out the healthcare franchise at C. K. Cooper”.
Mr. Kalia is a Chartered Financial Analyst. He has a Bachelor of Technology degree from Indian Institute of Technology, a Masters of Engineering from Stevens Institute of Technology and a MBA from the University of St. Thomas, in Minneapolis Minnesota.
About C. K. Cooper & Company
C. K. Cooper & Company is a full-service investment bank headquartered in Irvine, California. The Company is focused on providing superior and insightful research coverage to its clients; innovative investment banking solutions supported by sales and trading services; and portfolio advisory and management services for private clients. Though C. K. Cooper & Company has been noted for a variety of measures of accomplishment, we chart our success by only one metric: The growth of our clients. For more about C. K. Cooper & Company, visit
www.ckcooper.com.
For more information, please contact:
C. K. Cooper & Company
18300 Von Karman Ave.,
Suite 700,
Irvine CA 92612
(949) 477-9300
administration@ckcooper.com
The information contained herein is not a complete analysis of every material fact respecting any company, industry or security. Although opinions and estimates expressed herein reflect the current judgment of C. K. Cooper & Company, the information upon which such opinions and estimates are based is not necessarily updated on a regular basis; when it is, the date of the change in estimate will be noted. In addition, opinions and estimates are subject to change without notice. This report contains forward-looking statements, which involve risks and uncertainties. Actual results may differ significantly from the results described in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in "Investment Risks."
C. K. Cooper & Company from time to time perform corporate finance or other services for some companies described herein and may occasionally possess material, nonpublic information regarding such companies. This information is not used in the preparation of the opinions and estimates herein. While the information contained in this Report and the opinions contained herein are based on sources believed to be reliable, C. K. Cooper & Company has not independently verified the facts, assumptions and estimates contained in this Report. Accordingly, no representation or warranty, expressed or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information and opinions contained in this Report. C. K. Cooper & Company, its managing directors, its affiliates, and/or its employees may have an interest in the securities of the issue(s) described and may make purchases or sales while this report is in circulation.
administration@ckcooper.com
www.ckcooper.com
Source :
sharewellnewswire.com
